Approaching an individual methotrexate regimen in leptomeningeal carcinomatosis

Both parameters seem appropriate to describe the Mtx elimination from CSF. They should allow to individually adapt Mtx dosing towards an improvement of Mtx availability in CSF and of treatment efficacy.